Status:
COMPLETED
S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults
Lead Sponsor:
ZARS Pharma Inc.
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Pulsed dye laser (PDL) on the face is painful. For this reason, local anesthesia is commonly used to eliminate or minimize the pain. S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a eutectic ...
Detailed Description
This was a multi-center (5 centers), double-blind, placebo-controlled, parallel study that included 80 adults who met all the eligibility criteria and who were undergoing PDL therapy for the treatment...
Eligibility Criteria
Inclusion
- Patient is 18 years of age or older
- Patient elects to undergo PDL therapy for the treatment of vascular lesions on the face
Exclusion
- Patient is pregnant or breastfeeding
- Patient has participated in a clinical trial of an unapproved drug within the previous 30 days
- Patient has participated in any clinical trial involving S-Caine Peel
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2005
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00110773
Start Date
June 1 2005
End Date
October 1 2005
Last Update
June 5 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington Institute of Dermatologic Laser Surgery
Washington D.C., District of Columbia, United States, 20037
2
Midwest Cutaneous Research
Clinton Township, Michigan, United States, 48038
3
Laser and Skin Surgery Center of New York
New York, New York, United States, 10016